Goldman Sachs is out with its report today on Universal American UAM, upgrading UAM from Not Rated to Neutral.
In a note to clients, Goldman Sachs writes, "We have removed the Not Rated designation from UAM and moved to a Neutral rating, with a 12-month price target of $12. Our 2011E/2012E/2013E EPS go to -$0.20/$0.55/$0.80 from $1.80/$1.80/NA, with sequential EPS improvement driven by administrative cost reductions as UAM downsizes overhead associated with the divested Medicare PDP business (which accounts for all of our earnings revisions)."
Shares of UAM closed Thursday at $10.96, down 0.36% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst ColorUpgradesAnalyst RatingsGoldman SachsHealth CareManaged Health Careuniversal american
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in